15-year prospective follow-up of patient-reported outcomes of late bowel toxicity after external beam radiotherapy for localized prostate cancer. A comparison with age-matched controls
Authors:
Open Access
- 1 January 2007
- journal article
- research article
- Published by Medical Journals Sweden AB in Acta Oncologica
- Vol. 46 (4) , 517-524
Abstract
We have previously described patient-reported outcomes of late side effects induced by conventional external beam radiotherapy (EBRT), 4 and 8 years after treatment, in 181 patients with localized prostate cancer compared with 141 age-matched controls. In the present study, we compare bowel side effects 15 years after EBRT with the same controls, and with the results of our previous 4-year and 8-year follow-ups. Of the 181 patients and 141 controls at the 4-year follow-up, 45 patients (25%) and 79 controls (56%) were still alive at the 15-year follow-up. Bowel symptoms were assessed using the symptom-specific questionnaire Prostate Cancer Symptom Scale (PCSS), which was sent to these 45 patients and 79 age-matched controls with a mean follow-up time of 15 years (162–197 months) after EBRT. The answer frequency was 64% in the patient group and 52% in the control group. The mean age was 78 years in both groups. At the 15-year follow-up, 39% of the patients and 84% of the controls reported no bowel problems (p <0.001), while 16% of the patients and 0% of the controls reported “Quite a few/many” problems with mucus in the stools (p <0.001). “Quite a bit/much” stool leakage was reported by 20% of the patients at the 15-year follow-up, in comparison to 4% of the patients at the 4-year follow-up (ns). The proportion of patients reporting late bowel symptoms was unchanged 15 years after EBRT in comparison to the 4-year follow-up. Increased bowel symptoms were seen in patients in comparison to the age-matched controls.Keywords
This publication has 31 references indexed in Scilit:
- Update on Radiation Therapy in Prostate CancerHematology/Oncology Clinics of North America, 2006
- 3-D conformal radiotherapy of localized prostate cancer: A subgroup analysis of rectoscopic findings prior to radiotherapy and acute/late rectal side effectsRadiotherapy and Oncology, 2006
- Delayed rectal and urinary symptomatology in patients treated for prostate cancer by radiotherapy with or without short term neo-adjuvant androgen deprivationRadiotherapy and Oncology, 2005
- Radical Prostatectomy versus Watchful Waiting in Early Prostate CancerNew England Journal of Medicine, 2005
- Five-Year Outcomes After Prostatectomy or Radiotherapy for Prostate Cancer: The Prostate Cancer Outcomes StudyJNCI: Journal of the National Cancer Institute, 2004
- Time Course and Predictors of Symptoms After Primary Prostate Cancer TherapyJournal of Clinical Oncology, 2003
- Health Related Quality of Life in Men With Prostate CancerJournal of Urology, 2003
- Comprehensive Comparison of Health-Related Quality of Life After Contemporary Therapies for Localized Prostate CancerJournal of Clinical Oncology, 2002
- LONG-TERM BIOCHEMICAL DISEASE-FREE AND CANCER-SPECIFIC SURVIVAL FOLLOWING ANATOMIC RADICAL RETROPUBIC PROSTATECTOMYUrologic Clinics of North America, 2001
- Effect of pelvic radiotherapy for prostate cancer on bowel, bladder, and sexual function: The patient's perspectiveUrology, 1996